• Deferment for Active Cancer Treatment Act of 2017 (HR 2976), To amend the Higher Education Act of 1965 to allow for the deferment of certain student loans during a period in which a borrower is receiving treatment for cancer. American Health Care Act (HR 1628); Better Care Reconciliation Act; and reform bill by Senators Graham and Cassidy: provisions related to loss of insurance, increased health insurance premiums, reductions to Medicaid funding, and those negatively impacting access to care for cancer patients/survivors. Tax Cut and Jobs Act (H.R. 1): provisions impacting individual mandate to purchase insurance, the medical expense deduction, and the impact of sequestration on Medicare spending. Bipartisan Health Care Stabilization Act of 2017: legislation stabilizing the individual and small group insurance markets.
• FY 2018 funding for cancer research, survivorship and prevention services under the Labor, Health and Human Services appropriations bill. FY 2018 funding for the Congressionally Directed Medical Research Programs (cancer research, survivorship and prevention services) under the Department of Defense bill.
• Comments on Notice of Benefit and Payment Parameters for 2019 Proposed Rule, CMS 9930-P: portions of the proposal related to essential health benefits, network adequacy, and navigators. Informal Request for Information (RFI) regarding the Innovation Center at the Centers for Medicare & Medicaid Services: comments on strategies for testing new models of patient-centered patient care.

Duration: January 1, 2017 to December 31, 2017

General Issues: Health Issues, Budget/Appropriations, Medicare/Medicaid

Spending: about $90,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2017: U.S. Senate, House of Representatives, Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH)